Searched for
AJANTA PHARMA DIVIDEND
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
Power Grid shares to approach ex-date for Rs 4.5 per share interim dividend. Last chance to buyInvestors have a final chance today to buy Power Grid Corporation of India shares for a Rs 4.50 interim dividend. The stock will trade ex-d...
Ajanta Pharma shares jump over 13% on strong Q4 results, buyback plansAjanta Pharma shares jumped 13% to Rs 2,532 in Friday's trade on BSE after the firm's consolidated net profit increased 66% year-on-year (Y...
Ajanta Pharma Q4 Results: Net profit soars 66% YoY to Rs 203 crRevenue from operations rose to Rs 1,054 crore in the fourth quarter of FY24 as compared with Rs 882 crore in the year-ago period, Ajanta P...
Corporate actions this week: L&T, Maruti Suzuki to go ex-dividend, Piramal Pharma right issue and moreSeveral Indian companies will trade ex-dividend this week, including L&T, Crisil, Coforge, Maruti Suzuki, and Kotak Mahindra Bank. Ex-divid...
Stocks in news: Adani Enterprises, RailTel, IOC, SBI Card, Indian HotelsAdani Enterprises arm Adani New Industries has raised a trade finance facility of $394 million (Rs 3,231 crore) from Barclays and Deutsche ...
Corporate Radar: Ajanta Pharma to trade ex-dividend, LIC, M&M results and moreShares of Ajanta Pharma (Rs 7 per share), GMM Pfaudler (Re 1 per share), Siyaram Silk (Rs 4 per share) and Nikko Parks (Re 0.4 per share) w...
Tech Mahindra among 10 stocks to trade ex-dividend this weekSupreme Industries declared a special dividend of Rs 6/- per equity share. The stock shall trade ex-dividend on November 7, 2022. In the pa...
This smallcap pharma company declares 350% interim dividend; record date fixedPayment of interim dividend of Rs 7/- (350%) per equity share on the face-value of Rs 2/- per share for the Financial Year 2022-23,” said t...
Ajanta Pharma Q2 Results: Profit dips 20% YoY to Rs 156.6 croreThe company had posted a consolidated net profit of Rs 195.94 crore in the same period last fiscal, Ajanta Pharma said in a regulatory fili...
Corporate Radar: Navin Fluorine, Coforge to go ex-dividend, Adani Enterprises, Vodafone earnings and moreAmid the ongoing earnings season, Adani Enterprises, Ajanta Pharma, Amara Raja Batteries, Bank of India, Blue Star, HDFC, HPCL, Vodafone Id...
Corporate Radar: PNB, Union Bank to turn ex-dividend, SBI AGM; Q4 results, bonus issues & moreWednesday is also the record date for dividends by Britannia Industries, Bank of Maharashtra, Agro Tech Foods, Bliss GVS Pharma, Bharat Sea...
Corporate Radar: Q4 results, AGMs, dividends, preferential issues & moreAjanta Pharma board would consider bonus issue while disclosing its March quarter results.
Ajanta Pharma Q2 results: Profit up 15% at Rs 196 croreRevenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said...
Rally takes promoters of small-cap companies past the $1 billion markThe average stock return of these five companies has been almost seven times higher than the BSE Small Cap index over the past two years.
Pharma stocks that outperformed benchmark indicesIf you invest in quality stocks, you can beat benchmark equity indices. Even small amounts invested carefully in good companies can result ...
Ajanta Pharma Q4 net profit up 20% at Rs 84.31 croreAjanta Pharma reported 20 per cent rise in standalone net profit to Rs 84.31 crore for the quarter ended March 31, 2015 on robust sales.
Ajanta Pharma quarter 4 net surges over two-fold at Rs 70 croreAjanta Pharma today posted over two-fold increase in its net profit at Rs 70.09 crore for the quater ended March 31, 2014 on the back of ro...
- Ajanta Pharma Q4 net up 14.78% at Rs 27 crore
Ajanta Pharma today reported 14.78 per cent rise in net profit to Rs 27.09 crore for the quarter ended March 31, 2013 on account of robust ...
- Ajanta Pharma Q4 profit up 35% to Rs 23.59 crore
Ajanta Pharma today said its net profit rose by 35.10 per cent to Rs 23.59 crore for the fourth quarter ended March 31, 2012.